Calamos Strategic Total Return Fund

CSQ · NASDAQ

$19.75−$0.12 (−0.60%)TodayMarket closed ·
Prev close $19.87

About CSQ

Calamos Strategic Total Return Fund is a US-based company operating in industry. The company is headquartered in Naperville, Illinois. The company went IPO on 2004-03-26. Calamos Strategic Total Return Fund (the Fund) is a diversified, closed-end management investment company. The Fund’s investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in a diversified portfolio of equities, convertible securities, and high yield securities. The Fund, under normal circumstances, will invest at least 50% of its managed assets in equity securities (including securities that are convertible into equity securities). The Fund may invest up to 35% of its managed assets in securities of foreign issuers, including debt and equity securities of corporate issuers, and debt securities of government issuers in developed and emerging markets. The Fund holds investments in various sectors, such as information technology, consumer discretionary, financials, healthcare, industrials, consumer staples, energy, airlines, utilities, materials, and real estate. Calamos Advisors LLC is its investment advisor.

Employees
0
Headquarters
Naperville, Illinois
Listed
Mar 26, 2004
Sector
N/A
Industry
N/A

Leadership

Calamos Strategic Total Return Fund executives
NameTitleSince
John Calamos—2003
Thomas Herman——
Mark Mickey——
Erik Ojala——
Daniel Dufresne——
Thomas Kiley——
John Koudounis——
Stephen Atkins——
John Neal——
Virginia Breen——
William Rybak——
Karen Stuckey——
Christopher Toub——
Lloyd Wennlund——

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.